Deiodinase-3 is a thyrostat to regulate podocyte homeostasis

[1]  Jiajun Zhao,et al.  TSH activates macrophage inflammation by G13 and G15-dependent pathways. , 2021, Endocrinology.

[2]  B. Marcus-Samuels,et al.  TSH Receptor Homodimerization in Regulation of cAMP Production in Human Thyrocytes in vitro , 2020, Frontiers in Endocrinology.

[3]  A. M. Lavecchia,et al.  Alteration of thyroid hormone signaling triggers the diabetes-induced pathological growth, remodeling, and dedifferentiation of podocytes. , 2019, JCI insight.

[4]  A. Bianco,et al.  Paradigms of Dynamic Control of Thyroid Hormone Signaling. , 2019, Endocrine reviews.

[5]  R. Latif,et al.  Editorial: TSH Receptor and Autoimmunity , 2019, Front. Endocrinol..

[6]  J. Coresh,et al.  A tripartite complex of suPAR, APOL1 risk variants and αvβ3 integrin on podocytes mediates chronic kidney disease , 2017, Nature Medicine.

[7]  D. Scadden,et al.  Bone marrow-derived immature myeloid cells are a main source of circulating suPAR contributing to proteinuric kidney disease , 2016, Nature Medicine.

[8]  D. Baltimore,et al.  Absence of miR-146a in Podocytes Increases Risk of Diabetic Glomerulopathy via Up-regulation of ErbB4 and Notch-1* , 2016, The Journal of Biological Chemistry.

[9]  P. Davis,et al.  The thyroid hormone-αvβ3 integrin axis in ovarian cancer: regulation of gene transcription and MAPK-dependent proliferation , 2016, Oncogene.

[10]  J. Reiser,et al.  Podocytes , 2016, F1000Research.

[11]  S. Ishibe,et al.  Podocyte endocytosis in the regulation of the glomerular filtration barrier. , 2015, American journal of physiology. Renal physiology.

[12]  M. Schiffer,et al.  The Podocyte Power-Plant Disaster and Its Contribution to Glomerulopathy , 2014, Front. Endocrinol..

[13]  P. Larsen,et al.  Intracellular Inactivation of Thyroid Hormone Is a Survival Mechanism for Muscle Stem Cell Proliferation and Lineage Progression , 2014, Cell metabolism.

[14]  J. He,et al.  cAMP Signaling Prevents Podocyte Apoptosis via Activation of Protein Kinase A and Mitochondrial Fusion , 2014, PloS one.

[15]  R. Rossignol,et al.  Podocyte energy metabolism and glomerular diseases. , 2013, The international journal of biochemistry & cell biology.

[16]  J. Reiser.  Circulating permeability factor suPAR: from concept to discovery to clinic. , 2013, Transactions of the American Clinical and Climatological Association.

[17]  T. Visser,et al.  Metabolism of Thyroid Hormone , 2012 .

[18]  P. Larsen,et al.  β-Catenin regulates deiodinase levels and thyroid hormone signaling in colon cancer cells. , 2012, Gastroenterology.

[19]  J. Bixby,et al.  Neuronal Hypoxia Induces Hsp40-Mediated Nuclear Import of Type 3 Deiodinase As an Adaptive Mechanism to Reduce Cellular Metabolism , 2012, The Journal of Neuroscience.

[20]  A. Mohapatra,et al.  Interactions between thyroid disorders and kidney disease , 2012, Indian journal of endocrinology and metabolism.

[21]  L. Mariani,et al.  The renal manifestations of thyroid disease. , 2012, Journal of the American Society of Nephrology : JASN.

[22]  M. Holick,et al.  The thyroid hormone degrading type 3 deiodinase is the primary deiodinase active in murine epidermis. , 2011, Thyroid : official journal of the American Thyroid Association.

[23]  E. Salido,et al.  Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis , 2011, Nature Medicine.

[24]  M. Dentice,et al.  Deiodinases: the balance of thyroid hormone: local impact of thyroid hormone inactivation. , 2011, The Journal of endocrinology.

[25]  I. Stillman,et al.  Minimal-change renal disease and Graves’ disease: a case report and literature review , 2011, NDT plus.

[26]  F. B. Davis,et al.  Membrane receptor for thyroid hormone: physiologic and pharmacologic implications. , 2011, Annual review of pharmacology and toxicology.

[27]  B. Marcus-Samuels,et al.  Persistent cAMP signaling by thyrotropin (TSH) receptors is not dependent on internalization , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[28]  A. Bianco,et al.  Paracrine signaling by glial cell-derived triiodothyronine activates neuronal gene expression in the rodent brain and human cells. , 2010, The Journal of clinical investigation.

[29]  P. Iglesias,et al.  Thyroid dysfunction and kidney disease. , 2009, European journal of endocrinology.

[30]  Lai-cheng Wang,et al.  Presence of thyrotropin receptor in hepatocytes: not a case of illegitimate transcription , 2009, Journal of cellular and molecular medicine.

[31]  V. Darras,et al.  Large induction of type III deiodinase expression after partial hepatectomy in the regenerating mouse and rat liver. , 2009, Endocrinology.

[32]  R. Latif,et al.  Characterization of thyrotropin receptor antibody-induced signaling cascades. , 2009, Endocrinology.

[33]  G. Lippi,et al.  Prevalence of Subclinical Hypothyroidism in Patients with Chronic Kidney Disease , 2016 .

[34]  J. Harney,et al.  Hypoxia-inducible factor induces local thyroid hormone inactivation during hypoxic-ischemic disease in rats. , 2008, The Journal of clinical investigation.

[35]  N. Fontseré,et al.  [Graves disease, hypothyroidism, and minimal-change glomerulonephritis]. , 2008, Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia.

[36]  L. Wartofsky,et al.  Graves' disease. , 2007, The Journal of clinical endocrinology and metabolism.

[37]  W. Wiersinga,et al.  Induction of type 3 deiodinase activity in inflammatory cells of mice with chronic local inflammation. , 2005, Endocrinology.

[38]  Arturo Hernandez.  Structure and function of the type 3 deiodinase gene. , 2005, Thyroid : official journal of the American Thyroid Association.

[39]  Hung-Yun Lin,et al.  Integrin alphaVbeta3 contains a cell surface receptor site for thyroid hormone that is linked to activation of mitogen-activated protein kinase and induction of angiogenesis. , 2005, Endocrinology.

[40]  Y. Tomino,et al.  Podocyte Migration during Nephrotic Syndrome Requires a Coordinated Interplay between Cathepsin L and α3 Integrin* , 2004, Journal of Biological Chemistry.

[41]  J. Klein.  Physiological Relevance of Thyroid Stimulating Hormone and Thyroid Stimulating Hormone Receptor in Tissues other than the Thyroid , 2003, Autoimmunity.

[42]  J. Harney,et al.  Human Type 3 Iodothyronine Selenodeiodinase Is Located in the Plasma Membrane and Undergoes Rapid Internalization to Endosomes* , 2003, The Journal of Biological Chemistry.

[43]  C. Betsholtz,et al.  A new method for large scale isolation of kidney glomeruli from mice. , 2002, The American journal of pathology.

[44]  T. Akamizu,et al.  Renal Expression of Two ‘Thyroid-Specific’ Genes: Thyrotropin Receptor and Thyroglobulin , 2000, Nephron Experimental Nephrology.

[45]  J. Köhrle,et al.  The selenoenzyme family of deiodinase isozymes controls local thyroid hormone availability. , 2000, Reviews in endocrine & metabolic disorders.

[46]  J. C. Ramos-Dias,et al.  Iopanoic acid‐induced decrease of circulating T3 causes a significant increase in GH responsiveness to GH releasing hormone in thyrotoxic patients , 1999, Clinical endocrinology.

[47]  V. Chadha,et al.  Bilateral nephrectomy reverses hypothyroidism in congenital nephrotic syndrome , 1999, Pediatric Nephrology.

[48]  N. Marsh-Armstrong,et al.  Metamorphosis is inhibited in transgenic Xenopus laevis tadpoles that overexpress type III deiodinase. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[49]  D. D. Brown,et al.  The expression pattern of thyroid hormone response genes in remodeling tadpole tissues defines distinct growth and resorption gene expression programs. , 1998, Developmental biology.

[50]  C. Spitzweg,et al.  Thyrotropin receptor expression in adrenal, kidney, and thymus. , 1997, Thyroid : official journal of the American Thyroid Association.

[51]  R. Zeller,et al.  Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines. , 1997, Experimental cell research.

[52]  M. Berry,et al.  Recognition of UGA as a selenocysteine codon in Type I deiodinase requires sequences in the 3′ untranslated region , 1991, Nature.

[53]  M. Parmentier,et al.  Cloning, sequencing and expression of the human thyrotropin (TSH) receptor: evidence for binding of autoantibodies. , 1989, Biochemical and biophysical research communications.

[54]  V. Galton,et al.  The ontogeny of iodothyronine 5'-monodeiodinase activity in Rana catesbeiana tadpoles. , 1988, Endocrinology.

[55]  E. Kaptein.  Thyroid function in renal failure. , 1986, Contributions to nephrology.

[56]  H. Bräunlich.  Postnatal development of kidney function in rats receiving thyroid hormones. , 2009, Experimental and clinical endocrinology.

[57]  B. Smith,et al.  TSH RECEPTOR BINDING AND THYROID STIMULATION BY SERA FROM PATIENTS WITH GRAVES' DISEASE , 1983, Clinical endocrinology.

[58]  J. Coresh,et al.  A tripartite complex of suPAR, APOL1 risk variants and alpha(v)beta(3) integrin on podocytes mediates chronic kidney disease , 2022 .